2027 年亚太地区神经调节市场预测 - COVID-19 影响和区域技术分析（外部（非侵入性）神经调节和内部神经调节）；应用（慢性疼痛管理、腰背综合症、癫痫、震颤、失禁、抑郁症、肌张力障碍、胃轻瘫、帕金森病、强迫症和偏头痛）；最终用户（医院、诊所和家庭医疗保健）
No. of Pages: 117 | Report Code: TIPRE00016308 | Category: Life Sciences
No. of Pages: 117 | Report Code: TIPRE00016308 | Category: Life Sciences
市场介绍
神经调节是通过控制生理功能来调节神经活动的过程。神经递质的水平。这些改变是在各种设备的帮助下或通过药物输注实现的。这些设备包含放置在脊髓、大脑或周围神经上的小电极。脑血管疾病、阿尔茨海默病和帕金森病等神经系统疾病会影响身体的神经功能，因此可以借助神经调节来治疗。
市场概况和动态
亚太地区神经调节市场预计将达到3,518.34百万美元到 2027 年，从 2019 年的 15.5989 亿美元增长到 2027 年；预计2020年至2027年复合年增长率为11.0%。亚太地区神经调节市场的增长归因于神经系统疾病发病率的增加以及神经调节技术的不断发展。然而，神经调节设备的高成本促进了该地区市场的增长。导致限制市场的增长。
关键细分市场
根据技术，亚太神经调节市场分为外部（非侵入性）神经调节和内部神经调节。 2019年，内部神经调节领域占据了更大的市场份额。外部（非侵入性）神经调节预计在预测期内将以更快的速度增长。
主要来源和上市公司< /strong>
在准备亚太地区神经调节市场报告时提到的一些主要一手和二手来源是世界卫生组织、卫生部健康与预防，帕金森病和帕金森病运动障碍协会 (PDMDS)、 和 Garvan 研究所、 以及卫生和家庭福利部。
雅培、波士顿科学公司、美敦力、NeuroPace, Inc.、NeuroSigma, Inc.、NEVRO CORP、Synapse Biomedical Inc.、Soterix Medical Inc、Integer Holdings Corporation 和 Magstim。
< span>
亚太地区神经调节市场细分
公司简介
Strategic insights for Asia Pacific Neuromodulation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,559.89 Million |
| Market Size by 2027 | US$ 3,518.34 Million |
| Global CAGR (2020 - 2027) | 11.0% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Neuromodulation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - Asia Pacific Neuromodulation Market
The Asia Pacific Neuromodulation Market is valued at US$ 1,559.89 Million in 2019, it is projected to reach US$ 3,518.34 Million by 2027.
As per our report Asia Pacific Neuromodulation Market, the market size is valued at US$ 1,559.89 Million in 2019, projecting it to reach US$ 3,518.34 Million by 2027. This translates to a CAGR of approximately 11.0% during the forecast period.
The Asia Pacific Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Neuromodulation Market report:
The Asia Pacific Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Neuromodulation Market
